populations of cells mediate the direct (D 1 type) and indirect (D 2 type) pathway signals respectively, the net effect of DA depletion is likely to enhance the inhibitory basal ganglia output to the thalamocortical circuit. The similarity of therapeutic effects obtained from DBS and lesions of the STN and GPi are consistent with the hypothesis that DBS may mimic the effects of a lesion by disabling (inhibiting) the nuclei ( Figure 1 ). Some electrophysiological evidence does support this local inhibition theory for the action of DBS. Dostrovsky et al. (2000) recorded neural activity in the GPi during surgical implantation of stimulation electrodes. Profound inhibition was observed at stimulation frequencies ranging from 5 to 300 Hz. High frequency stimulation (HFS) of the STN also produced long lasting inhibition of the STN and substantia nigra pars reticulata (SNr) in anesthetized rats (Benazzouz et al., 2000) .
A number of in vitro studies have been performed to investigate the channel and membrane property changes induced by DBS. Beurrier et al. (2001) conducted a patch clamp study in brain slices and reported that HFS similar to that used in the clinic to treat PD inactivates the STN. This result was attributed to the blockade of persistent Na + , L-and T-type Ca 2+ currents. Magarinos-Ascone et al. (2002) found time-dependent responses of STN neurons during DBS in an in vitro slice preparation. The neurons in the STN initially followed HFS beyond 100 spikes/s. After 10 s of HFS, the cells switched to a burst firing mode and then totally shut down after another 10 s. Like Beurrier et al. (2001) the authors attributed the silencing effect of HFS on STN neurons to the inactivation of Na + mediated action potentials. A recent study by Do and Bean (2003) examined dynamic firing patterns in dissociated rat STN neurons. They found that a resurgent Na + current, together with a persistent Na + current, may be responsible for the generation of high tonic firing and burst firing patterns in STN neurons. These two Na + currents were under the regulation of a slow inactivation process to maintain a constant firing rate.
In contrast to the previous findings which suggested that HFS silenced STN cells, Do and Bean (2003) found that 75 Hz stimulation could drive a subpopulation of STN cells to fire at a higher, yet regular firing. Thus, the authors suggested that the firing pattern, rather than the firing rate, of the STN neurons could account for the therapeutic effects of DBS. However, caution must be exercised in the interpretation of in vitro experiments since normal anatomic connections of STN neurons are severed preclude DBS-induced changes in network processing from being investigated. In addition, the specifically selected stimulation parameters that produce the electrophysiological results in such experiments may not be equivalent to those used in behaving subjects with therapeutic benefits (Chang et al., 2003; Hashimoto et al., 2003) .
Recent studies have shown that the effects of DBS on the projection areas of the STN are inconsistent with the simple view that DBS works by inactivation. An increased firing rate in the GPi with stimulation has been demonstrated in behaving primates (Hashimoto et al., 2003) . In this study the GPi neurons discharged 3 to 4 ms after the STN stimulation pulse and the effects of DBS on GPi firing rates and behavioral benefits appear to be co-dependent upon stimulus intensity. This correlation between an increase in pallidal neuron firing rates and therapeutic benefits is inconsistent with the classic model of the basal ganglia thalamocortical pathway which predicts that enhanced inhibitory output from GPi would further inhibit the thalamocortical feedback loop and thereby worsen the parkinsonian motor symptoms. Anderson et al. (2003) recorded neural activity in the motor thalamus during high frequency stimulation of the GPi in a monkey model of PD and corroborated Hashimoto's findings by showing a decrease in motor thalamic activity during DBS. These findings raise the possibility that DBS may differentially act on cell bodies and axons in the stimulation sites. This hypothesis was supported by a computer modeling study that indicated that high frequency stimulation can simultaneously suppress cell bodies and excite axons (McIntyre and Grill, 1999) . Together with the finding that STN-high frequency stimulation induced increase in glutamate release in the SNr (Windels et al., 2000) , these results suggest that the postulated overactivation of basal ganglia output, as
represented by high firing rates in the GPi and SNr and low firing rate in the motor thalamus in the Parkinsonian condition, may not be the pathophysiological attribute responsive to DBS treatment. Both
Hashimoto and Anderson's studies did show, however, a reduced burst firing pattern during DBS, which may support the notion that DBS may exert its therapeutic effects via a modulation of basal ganglia firing patterns rather than by changing firing rates. Similar results have also been observed with a rodent model of DBS (Chang et al., 2002) . In summary, these latter findings suggest that DBS induced increases in GPi firing rates and decreases in thalamic firing rates, though abnormal, may effectively interrupt pathogenetic bursts or oscillatory firing patterns and thus improve parkinsonian syndromes.
Dystonia.
DBS has also been tested in other movement disorders such as dystonia and essential tremor.
Dystonia is a hyperkinesia disorder characterized by uncontrollable movements of antagonist muscles.
Electrophysiologic studies have demonstrated a decrease in neural activity in the basal ganglia output regions, such as the GPi in this condition (Vitek et al., 1999) . Such findings are in line with the model of reduced basal ganglia inhibitory output for hyperkinetic disorders, like dystonia. However, a recent study (Hutchison et al., 2003) has challenged this hypothesis by showing similar spike frequencies of GPi neurons in patients with dystonia and patients with PD. The authors attribute the discrepancy of the results to the use of propofol anesthesia, which can significantly reduce spike activity in GPi neurons.
As DBS of the GPi has proven to be effective in alleviating dystonia syndromes as well as PD symptoms, the mechanisms underlying GPi stimulation on behavioral improvements are more likely to involve modulation of network firing patterns rather than simple GPi inhibition. However, pilot studies exploring STN stimulation as a treatment for dystonia have pointed to other possible mechanisms.
Interestingly, high frequency stimulation of the STN worsens dystonia symptoms while low frequency stimulation improves these symptoms (Benabid et al., 2001 ). This result fits well with the hypothesis that while high frequency stimulation of the STN may be inhibitory, low frequency stimulation of the STN could be excitatory, which in turn would enhance GPi inhibitory output thus reducing the hyperkinesia associated with dystonia.
Epilepsy.
Approximately 10% of epileptic cases can be classified as medically intractable, unresponsive to drug treatments and without a defined epileptic focus amenable to surgical removal. This significant population of several million patients could potentially benefit from DBS therapy ( Figure 2 ).
Initial attempts to use brain stimulation to treat epileptic patients started in the 1970's. Because the cerebellum has abundant inhibitory GABAegic Purkinje cell output, it was selected as a stimulation site (Cooper et al., 1973) . In an open study, Davis and his colleagues found long lasting beneficial effects of cerebellum stimulation on tonic-clonic and complex partial seizures (Davis and Emmonds 1992).
The thalamus is the critical region for relaying neural signals to the cerebral cortex and is thought to be involved in the epileptogenic process. A number of studies have explored the therapeutical potential of thalamic stimulation for epilepsy treatment. Cooper and his colleagues stimulated the anterior thalamic nucleus to treat complex partial epilepsy on the grounds that this region relays limbic signals to the cingulate cortex (Cooper and Upton, 1985) . A recent study also showed beneficial effects of anterior thalamic stimulation on generalized tonic-clonic seizures (Lozano et al., 2000) . The centromedian thalamus (CM) is another thalamic region that is relevant to epileptogenesis. Velasco et al., (1987) first reported beneficial effects of CM stimulation on seizure control. Later, a long-term study of CM stimulation effects revealed a persistent decrease in generalized tonic-clonic seizures for a period of 7 to 33 months (Velasco et al., 1995) . However, a double-blind, cross-over study did not show significant effects of CM stimulation on intractable seizures (Fisher et al., 1992) . A recent mapping study suggested that this discrepancy of results may be attributable, at least in part, to differing stimulation loci within the CM. Selective stimulation of the ventral lateral part of the CM could recruit and desynchronize the direct current shift response, and this response was directly correlated with desired antiepileptic effects (Velasco et al., 2000) . In addition to stimulating potential pathways of epileptic network, recent reports showed that DBS directly targeting the seizure focus had beneficial effects on intractable temporal lobe seizures (Vonck et al., 2002) .
The basal ganglia have been hypothesized to be involved in the transition from limbic to generalized motor seizures. Early reports by Hayashi (1952) The system is thought to control seizures by the nigrotectal pathway. Garant and Gale (1987) reported that bilateral ablation of the superior colliculus in rats abolished the anticonvulsant effect of microinjection of muscimol, a GABA agonist, into the substantia nigra. This result suggests that anticonvulsant effects of nigral manipulation are a result of the disinhibition of neurons in the superior colliculus that receives G\ABAergic inhibitory input from the SNr. Other basal ganglia structures, either directly or indirectly connected to the SNr, may also influence epileptic seizures. GABA receptor antagonists microinjected into the striatum have been shown to prevent amygdala kindling-induced seizures in the rat (Cavalheiro et al., 1987) . A number of recent studies have focused on the role of the STN in epileptic seizures. GABA receptor agonist infusion into the STN significantly reduces flurothylinduced clonic seizures, probably by decreasing excitatory input to the SNr (Veliskova et al., 1996) . (Morimoto and Goddard, 1987) .
However, low frequency stimulation (10-30 Hz) of the SNr also inhibited cortical epileptiform spikes.
This result was attributed to inhibition of the thalamocortical re-exciting loop (Sabatino et al., 1988) .
Since epileptiform discharge is characterized by hypersynchronized action potentials, it may be that DBS works by disrupting network synchronization, rather than by simply inhibiting the local circuit.
Evidently, in order for stimulation to block seizure activity it needs to be applied to a pivotal structure in the network that gates the propagation of epileptiform activities. Presently, the SNr is an attractive candidate for such a pivotal structure in kindled and chemical induced seizures, however it is not known whether other structures may play a critical role in the propagation of other types of epileptic seizures.
Pain.
Clinical application of DBS to treat intractable pain started half century ago (Pool et al., 1956 ).
Several brain regions have since been identified as promising targets for DBS treatment of pain, including the somatosensory thalamic nuclei (Mazars, 1975) , the motor cortex (Tsubokawa et al., 1993) , the internal capsule (Adams et al.,1974) , periaqueductal gray area, pariventricular gray, the raphe nuclei (Oliveras et al., 1978) activates descending pathways through the raphe nuclei in the ventral periaqueductal gray and inferior to the locus coeruleus. Serotoninergic fibers from the raphe nuclei and noradrenergic fibers from the locus coeruleus then project through the dorsolateral funiculus to the dorsal horn of the spinal cord (Hosobuchi et al., 1979; Young et al., 1993) . This input may activate opioid interneurons which inhibits the conduction of signals from noxious stimuli. This model is supported by the finding that lesions of the dorsolateral funiculus blocked both morphine and periaqueductal gray stimulation induced analgesia (Basbaum et al., 1976) .
The mechanisms for the analgesic effects induced by somatosensory thalamus stimulation have not been elucidated. One hypothesis postulated by Mazars is that deafferentation pain is caused by a loss of proprioceptive signals reaching the sensory thalamus. Thalamic stimulation may therefore be able to compensate this loss of sensory input (Mazars, 1975) . The somatosensory thalamus relays peripheral sensory signals to the cortex so it is no surprise that stimulation of these critical relay nuclei in the It may also be that antidromic activation of descending nociceptive modulating pathways mediates analgesia effects of thalamic stimulation. Gerhart et al. (1983) reported that stimulation of the ventral posterior lateral thalamus nucleus could inhibit spinothalamic tract neurons in anesthetized monkeys.
The response of spinothalamic tract neurons to electrical stimulation of A and C fibers in the sural nerve were reduced during thalamic stimulation. Lesioning of the dorsolateral funiculi bilaterally blocked the inhibitory effects of thalamic stimulation. A correlation between pariventricular gray stimulation and sensory thalamus responses was reported recently (Nandi et al., 2002) . Low frequency stimulation (2-25
Hz) of the pariventricular gray produced coincident reduction of 0.2-0.4 Hz thalamic field potentials and relief of pain. Meanwhile high frequency (50-100 Hz) pariventricular gray stimulation neither altered thalamic field potentials nor the pain syndrome. Since the onset of changes in thalamic activity and pain threshold are almost instantaneous, direct neural circuits, in addition to the descending endogenous opioid pathway, are expected to be involved in this pariventricular gray stimulation effects. It is likely that thalamic stimulation could activate both thalamocortical and descending inhibitory pathways to modulate nociceptive processes.
Chronic motor cortex stimulation has been used recently to treat neuropathic facial pain (Rainov and Heidecke, 2003), deafferentation pain (Tsubokawa et al., 1993) and complex regional pain syndrome (Son et al., 2003) . Stimulation of the cortical region capable of triggering stimulation induced muscle contraction in the affected limb generated a potent analgesic effect in that limb with the stimulation intensity set below the threshold for muscle contraction. Beneficial effects of motor cortex stimulation on deafferentation pain may be attributable to an inhibition of hyperactivity of deafferented nociceptive neurons and/or activation of non-nociceptive fourth order sensory neurons that inhibit hyperactive nociceptive neurons in the sensory cortex (Tsubokawa et al., 1993) . An intact cortical spinal tract seems to be necessary to ensure effective analgesic results of motor cortical stimulation, suggesting that the mechanism involves modulation of the spinal nociceptive reflex (Katayama et al., 1998) .
In spite of extensive research and a long history of clinical application, there is no standard protocol for DBS treatment of pain, partially because of the variety of clinical pain symptoms. Clinical results, target selection and stimulation parameters have varied widely among reports (Levy et al., 1987) . Well designed studies with sham-controlled, double-blind procedures and precise, subjective pain measures are needed to make a resounding evaluation of DBS effects on clinical pain management.
Psychiatric disorders.
The recently developed transcranial magnetic stimulation (TMS) technique has been replacing the common practice of electric shock as the preferred alternative in the treatment of a variety of psychiatric disorders such as depression and schizophrenia. TMS is a noninvasive, painless brain stimulation method that uses a magnetically induced current to stimulate the cortical regions of the brain. The method was first introduced by Barker et al. (1985) and has since been widely used as a powerful research and clinical tool. This technique can be used to study many basic central nervous system functions such as motor control, visual processing, neural plasticity, memory, speech and mood.
Depression.
Attempts to use TMS to treat depression started a decade ago. Antidepressive effects of low frequency TMS applied to the vertex were reported in small open studies (Hoflich et al., 1993) . These pilot studies led to further exploration seeking better approaches of TMS treatment. Based on the known therapeutic effects of electroconvulsive therapy and evidence of abnormal frontal cortex function in depression, frontal cortex was selected as a target for TMS treatment. A lateralized effect of rapidrate transcranial magnetic stimulation (rTMS) was discovered in healthy adult human subjects. Left prefrontal cortex stimulation resulted in increased sadness ratings and decreased happiness ratings in comparison with ratings reported with right prefrontal cortex stimulation (Pascual-Leone et al., 1996) .
Early attempts to use rTMS on the prefrontal cortex in medication resistant depressed patients however yielded contradictory results to that seen in the healthy subjects. Right prefrontal cortex stimulation, worsened, rather than improved, mood and anxiety ratings in depressed subjects. However, left prefrontal cortex rTMS significantly improved depression scores in depressed patients (George et al., 1998) .
With the aim of understanding its action, imaging techniques have been employed to map brain activity during rTMS. A positron emission tomography study revealed opposite effects of high vs. low frequency rTMS of the left prefrontal cortex on regional cerebral blood flow (CBF) in depressed patients.
High frequency (10-20 Hz) rTMS significantly increased CBF bilaterally in frontal, limbic and paralimbic regions while low frequency stimulation (1-10 Hz) decreased CBF in selected cortical and basal ganglia regions. The change in mood following the tow rTMS frequencies were inversely related such that individual who improve with one frequency worsened with the other (Speer et al., 2000) . The mechanism of the lateralized antidepressive effects generated by rTMS of the prefrontal cortex is unclear. But it seems that low and high rTMS of the right and left prefrontal cortices, respectively, can induce similar antidepressive effects (Klein et al., 1999a) .
Schizophrenia.
TMS treatment of schizophrenia has been tested recently and produced mixed results. Stimulating the right prefrontal cortex with low frequency rTMS produced only marginal effects on core psychotic symptoms in schizophrenic patients (Klein et al., 1999b) . However, successful rTMS treatment of schizophrenic auditory hallucinations has been reported. Hoffman and his colleagues found that 1 Hz rTMS applied to the left temporoparietal cortex significantly reduced auditory hallucinations in medication-resistant schizophrenic patients in double-blind, cross-over and parallel trials (Hoffman et al., 2000) . The effect was attenuated by anticonvulsant agents, suggesting that the propagation of neural signals from the temporoparietal cortex to a more distributed network is crucial for the therapeutic rTMS effects (Hoffman et al., 2000) .
Overall, brain stimulation for psychiatric disorders is still in an early experimental stage. Clinical application of TMS has not been standardized and reports from different groups can not be compared reliably due to the variation in stimulation parameters, experimental designs, patient selection and evaluation criteria. Large scale, long term studies are needed to translate this experimental procedure into standard clinical practice. Furthermore, the mechanism underlying the therapeutic effects of TMS is speculative at most. Better imaging techniques capable of capturing brain activity with high temporal and spatial resolution during TMS will help to define the brain regions activated by the stimulation.
Animal models of depression and schizophrenia are important for understanding how TMS works.
Several studies have reported TMS-induced changes in neurotransmitter systems. For example, BenShacher et al., (1997) found that a single 25 Hz TMS session in the rat brain increased the DA turn-over rate in the frontal cortex and increased striatal and hippocampal dopamine levels. In addition to modulation of transmitter levels, TMS has been reported to alter the number of monoamine receptors in the animal brain, a single rTMS treatment induced a significant increase in 5-HT 1A receptor binding in the frontal and cingulate cortices and the olfactory nucleus (Kole et al., 1999) . It should be noted however that caution needs to be exercised in interpreting the results from animal studies due to poor spatial resolution of stimulation sites and questionable behavioral models.
Summary and future directions. 
